 | |
| Combination of | |
|---|---|
| Ciprofloxacin | Antibiotic |
| Dexamethasone | Corticosteroid |
| Clinical data | |
| Trade names | Ciprodex, others |
| AHFS/Drugs.com | Monograph |
| MedlinePlus | a607010 |
| Routes of administration | Ear drop[1] |
| Legal status | |
| Legal status | |
Ciprofloxacin/dexamethasone, sold under the brand name Ciprodex among others, is a combination medication used to treat acute otitis media in those with tympanostomy tubes or acute otitis externa.[1] It may be used in those who are at least 6 months old.[1] It is used as an ear drop.[1]
Common side effects include ear pain and ear itchiness.[1] Other side effects may include anaphylaxis.[1] It contains the antibiotic, ciprofloxacin (0.3%) with the corticosteroid, dexamethasone (0.1%).[1] It is effective against a number of bacteria including Pseudomonas aeruginosa.[1]
The combination was approved for medical use in the United States in 2003.[1] It is available as a generic medication.[3] In the United Kingdom a 5 ml bottle costs the NHS about £6 as of 2021.[3] It costs about 63 USD in the United States as of 2023.[4]
References
edit- ^ a b c d e f g h i j k l "Ciprodex- ciprofloxacin and dexamethasone suspension/ drops". DailyMed. U.S. National Library of Medicine. 12 December 2019. Archived from the original on 24 January 2021. Retrieved 5 November 2020.
- ^ Human Medicines Evaluation Division (14 January 2021). "Active substance: ciprofloxacin hydrochloride / dexamethasone acetate (ear drops, suspension)" (PDF). List of nationally authorised medicinal products. Europeans Medicines Agency. Archived (PDF) from the original on 30 June 2023. Retrieved 31 October 2021.
- ^ a b c BNF 81: March-September 2021. BMJ Group and the Pharmaceutical Press. 2021. p. 1242. ISBN 978-0857114105.
- ^ "Ciprofloxacin / Dexamethasone". GoodRx. Archived from the original on 10 July 2021. Retrieved 25 May 2023.